An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gilead Sciences (Nasdaq: GILD) will release its Q2 2022 financial results on August 2, after market close. A webcast discussing the results will be held at 4:30 p.m. Eastern Time that same day. Gilead is a biopharmaceutical company focused on developing innovative medicines for life-threatening diseases, including HIV, viral hepatitis, and cancer. With over three decades of breakthroughs, Gilead operates in more than 35 countries, headquartered in Foster City, California.
Positive
None.
Negative
None.
FOSTER CITY, Calif.--(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2022 financial results will be released on Tuesday, August 2, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s second quarter 2022 financial results and will provide a business update.
A live webcast will be available on the investor relations section of investors.gilead.com and will be archived there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
When will Gilead Sciences release its Q2 2022 financial results?
Gilead Sciences will release its Q2 2022 financial results on August 2, 2022, after market close.
What time is Gilead's Q2 2022 financial results webcast?
The webcast for Gilead's Q2 2022 financial results will be held at 4:30 p.m. Eastern Time on August 2, 2022.
How can I access Gilead's Q2 2022 financial results webcast?
The webcast can be accessed through the investor relations section of Gilead's website at investors.gilead.com.
What is Gilead Sciences known for?
Gilead Sciences is known for its breakthroughs in biopharmaceuticals, focusing on the treatment of life-threatening diseases such as HIV, viral hepatitis, and cancer.
